We are a global investment advisor in healthcare with a focus on oncology. Nextech is run by an experienced team of industry experts and supported by leading key opinion leaders in oncology. We deploy our expertise to invest equity in cancer companies with game changing discoveries in the fields of therapeutics, medical technologies and diagnostics.
61
Total Investments
43
Portfolio Companies
-
Exits
1
Industries
General Information
Industries
Health Care
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Nextech Invest
Recent Investments (61)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series F | •••••• | Jan 2026 | |
| Series B | •••••• | Dec 2025 | |
| Series C | •••••• | Oct 2025 | |
| Series B | •••••• | Apr 2025 | |
| Series D | •••••• | Sep 2024 | |
|
|
Series C | •••••• | Jul 2024 |
|
|
Private Placement Vc | •••••• | May 2024 |
|
|
Series B | •••••• | Apr 2024 |
|
|
Series E | •••••• | Mar 2024 |
|
|
Series E | •••••• | Mar 2024 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.